Head-to-head comparison of two SGLT-2 inhibitors on AKI outcomes in a rat ischemia-reperfusion model.

Ampersand Biosciences was cited in the article titled, “Head-to-head comparison of two SGLT-2 inhibitors on AKI outcomes in a rat ischemia-reperfusion model” for sample testing services that measured urinary kidney injury molecule-1 (KIM-1) using a sandwich enzyme immunoassay.

Species: Rat
Focus: Acute Kidney Injury (AKI)